Literature DB >> 6601189

Experimental Pneumocystis carinii pneumonia in C3H/HeJ and C3HeB/FeJ mice.

P D Walzer, M E Rutledge, K Yoneda.   

Abstract

C3H mice develop heavier degrees of Pneumocystis carinii pneumonia than other mouse strains tested. We have compared P. carinii pneumonia in two strains of C3H mice: C3H/HeJ mice, which are unresponsive to the effects of bacterial lipopolysaccharide (LPS), have defects in macrophage function, and have increased antibody responses to orally administered T-dependent antigens; and C3HeB/FeJ mice, which are immunologically normal. P. carinii pneumonia was induced by corticosteroids, and the intensity of the infection was judged by a semiquantitative histopathologic scoring system. Heavier degrees of infection were found in C3H/HeJ mice than in C3HeB/FeJ mice. Serum antibodies to P. carinii, measured by an indirect fluorescent antibody technique, were mainly of the IgG class in both strains of mice and varied inversely with the intensity of P. carinii infection in the lungs. Antibody levels were significantly higher in C3H/HeJ mice than in C3HeB/FeJ mice. These data suggest that C3H/HeJ have increased susceptibility to the effects of steroids of host defenses against P. carinii, and heightened serum antibody responses to the organism.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6601189

Source DB:  PubMed          Journal:  J Reticuloendothel Soc        ISSN: 0033-6890


  3 in total

1.  Immunodeficient and immunosuppressed mice as models to test anti-Pneumocystis carinii drugs.

Authors:  P D Walzer; J Runck; P Steele; M White; M J Linke; C L Sidman
Journal:  Antimicrob Agents Chemother       Date:  1997-02       Impact factor: 5.191

2.  Improved rat model of Pneumocystis carinii pneumonia: induced laboratory infections in Pneumocystis-free animals.

Authors:  C J Boylan; W L Current
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

3.  Single and combined humoral and cell-mediated immunotherapy of Pneumocystis carinii pneumonia in immunodeficient scid mice.

Authors:  J B Roths; C L Sidman
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.